This semester the UArizona opened the new Peter and Nancy Salter Medical Device Design Lab for undergraduate students majoring in biomedical engineering and other engineering fields. Dr. Philipp Gutruf, a UArizona assistant professor of biomedical engineering and BIO5 member, discusses the educational value of giving students access to state of the art equipment that can help them manufacture and design circuit boards or custom enclosures for wearable devices.
BIO5 connects and mobilizes hundreds of world-class researchers to develop creative solutions for complex challenges such as disease, hunger, water and food safety, and other health issues facing Arizona and the world. This interdisciplinary approach from BIO5 researchers, including Drs. Jennifer Barton, Judith Su, and DK Kang, has resulted in disease prevention strategies and promising new therapies, innovative diagnostics and devices, and improved food crops.
At least two independent research teams in the United States are developing technology to measure how much COVID-19 is in sewage water to help track how the virus spreads. One of those teams is led by Dr.
Researchers at the University of Arizona College of Medicine – Tucson have invented a new respiratory-assist device, or RAD, that provides fast, safe relief to those who experience difficulty breathing. Dr. Sairam Parthasarathy, professor of medicine and chief of the UArizona Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and Dr. Marvin Slepian, Regents Professor of Medicine and director of the UArizona Center for Accelerated Biomedical Innovation, created the new device: a small-scale, low-pressure heliox rebreathing system that simultaneously removes carbon dioxide while appropriately adjusting for humidity as it recirculates gasses in a closed system. To battle one of the major complications of COVID-19, inflammation in the respiratory tract and lungs that can lead to life-threatening pneumonia, the fast and safe application of a RAD can make the difference between life and death.
Amid the COVID-19 pandemic, hospitals across the world are running short on personal protective equipment, including N95 respirators – masks that, unlike surgical masks, fit tightly around the face and are capable of filtering out 95% of airborne particles. A group of UArizona researchers, including Dr. Doug Loy, a Department of Materials Science and Engineering professor and BIO5 member, is responding to the shortage by designing, 3D printing, and testing masks for health care workers.
UArizona researchers and staff at all levels are working to assemble COVID-19 collection kits. Led by Dr. David T Harris, Arizona Health Sciences Biorepository executive director, UArizona Department of Immunobiology professor, and BIO5 faculty member, research staff had begun producing the kits over the weekend, ultimately assembling more than 1,600 kits. Dr. Harris said that while assembling the collection kits is fairly easy, it's finding the materials for those kits that's the difficult part. Despite already making nearly 2,000 of these collection kits over the weekend, Dr. Harris said staff aim to assemble 10,000 over the next two weeks.
Scientists are developing new ways of collecting and analyzing biomarkers in sweat. UArizona BIO5 faculty members Dr. Erin Ratcliff and Dr. Esther Sternberg from the College of Engineering and the College of Medicine-Tucson, respectively, are leading research that could allow physicians to use patient sweat samples as a less invasive approach to establishing and monitoring health.
BIO5 director and UArizona Biomedical Engineering professor Dr. Jennifer Barton recently spoke with SPIE - the international society for optics and photonics, where she serves at the co-chair for their BiOS program. During their conversation, Dr. Barton gave a conceptual tour of the labs of Drs. Clara Curiel, Philipp Gutruf, D.K. Kang, and Judy Su, and discussed how their research is impacting bioscience fields.
A team of researchers, including UArizona Biomedical Engineering professor and BIO5 member Dr. Philipp Gutruf, have developed a device that could provide unique insight into the mechanisms of pain, depression, addiction and certain diseases. The ultra-small, wireless, battery-free device uses light to record individual neurons so neuroscientists can see how the brain is working.
Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the University of Arizona, has been licensed to startup ElectroSonix. Dr. Russell Witte, BIO5 faculty and Medical Imaging professor at the UArizona College of Medicine-Tucson, developed the patented technology that provides improvements over current cardiac imaging technologies such as electroanatomical mapping, which provides low-resolution images that make it difficult to pinpoint the exact location of cardiac arrhythmias.
Dr. Jennifer Barton, University of Arizona professor of biomedical engineering and director of the BIO5 Institute, has been appointed to the National Advisory Council for Biomedical Imaging and Bioengineering, part of the National Institutes of Health. The council advises the leadership of the National Institute of Biomedical Imaging and Bioengineering, or NIBIB, on policies and priorities related to research, training and health information dissemination in the areas of biomedical imaging and engineering.
To better understand biological processes, researchers at the University of Arizona have developed new materials for detecting radioisotopes that provide faster and higher resolution results than today’s generally accepted methods. These materials were developed by a team of researchers including the BIO5 Institute's Dr. Craig Aspinwall professor in the UA Departments of Chemistry and Biochemistry, Biomedical Engineering, and also a member of the Cancer Center and Sarver Heart Center at the UA College of Medicine – Tucson.
A team led by UArizona Department of Chemistry and Biochemistry professor and BIO5 member Dr. Jeffrey Pyun, has developed new lens materials polymers that are stronger, more temperature resistant, transparent to a wider spectral window, and less expensive than the first-generation sulfur plastic developed in 2014. The material could bring consumers affordable access to consumer-grade infrared detectors in products such as autonomous cars and in-home thermal imaging for security or fire protection.
Because of routine PSA testing in older men, cancers that might have gone undetected without ever causing health problems were identified and treated. Dr. Richard Ablin, the pioneer who discovered PSA recognizes some variables to prostate cancer screening that require close attention when evaluating men
Firefighters and advocates from across Arizona gathered Thursday for the first meeting of a state Senate ad hoc committee tasked with tackling the issue of cancer among first responders. During the first meeting, the University of Arizona’s Dr. Jeff Burgess gave a presentation on his nearly 20 years of studying
An easy-to-use, self-administered blood test that quickly could evaluate a person’s radiation exposure would help triage emergency medical treatment in the event of a radiological or nuclear event. The U.S. Department of Health and Human Services long has sought ways to monitor a population’s radiation
With the support of a new $3.8 million grant from the National Institute on Aging, a team of researchers, led by UA Department of Psychology professor and BIO5 member Dr. Gene Alexander, will investigate whether near-infrared light could help enhance cognition and reduce Alzheimer's disease risk in older adults. Dr. Ted Trouard, a BIO5 member and UA Biomedical Engineering professor, will serve as a co-investigator on the project.
By using $2.1 million in funding from the National Institute of Neurological Disorders and Stroke, a UArizona team of researchers led by Biomedical Engineering associate professor and BIO5 member Dr. Nan-kuei Chen, is looking to develop faster MR technologies to accommodate challenging patient populations. The research aims to provide higher-resolution images with richer information, giving health care practitioners more information about the stage of a disease and the ability to detect brain signal abnormality for those afflicted with diseases like Parkinson's.